Abstract

Transitioning from pluripotency to differentiated cell fates is fundamental to both embryonic development and adult tissue homeostasis. Improving our understanding of this transition would facilitate our ability to manipulate pluripotent cells into tissues for therapeutic use. Here, we show that membrane voltage (Vm) regulates the exit from pluripotency and the onset of germ layer differentiation in the embryo, a process that affects both gastrulation and left-right patterning. By examining candidate genes of congenital heart disease and heterotaxy, we identify KCNH6, a member of the ether-a-go-go class of potassium channels that hyperpolarizes the Vm and thus limits the activation of voltage gated calcium channels, lowering intracellular calcium. In pluripotent embryonic cells, depletion of kcnh6 leads to membrane depolarization, elevation of intracellular calcium levels, and the maintenance of a pluripotent state at the expense of differentiation into ectodermal and myogenic lineages. Using high-resolution temporal transcriptome analysis, we identify the gene regulatory networks downstream of membrane depolarization and calcium signaling and discover that inhibition of the mTOR pathway transitions the pluripotent cell to a differentiated fate. By manipulating Vm using a suite of tools, we establish a bioelectric pathway that regulates pluripotency in vertebrates, including human embryonic stem cells.

The plasma membrane’s electrical potential is maintained by ion channels, though the impact of this potential on cell fate has not been clearly elucidated. Here they show that changes in membrane potential can affect calcium levels and mTOR in pluripotent stem cells, altering their transition from pluripotency to differentiation.

Details

Title
Membrane potential drives the exit from pluripotency and cell fate commitment via calcium and mTOR
Author
Sempou, Emily 1 ; Kostiuk, Valentyna 1 ; Zhu, Jie 2 ; Cecilia Guerra, M. 3 ; Tyan, Leonid 4   VIAFID ORCID Logo  ; Hwang, Woong 1 ; Camacho-Aguilar, Elena 3   VIAFID ORCID Logo  ; Caplan, Michael J. 2 ; Zenisek, David 2   VIAFID ORCID Logo  ; Warmflash, Aryeh 3 ; Owens, Nick D. L. 5   VIAFID ORCID Logo  ; Khokha, Mustafa K. 1   VIAFID ORCID Logo 

 Yale University School of Medicine, Pediatric Genomics Discovery Program, Departments of Pediatrics and Genetics, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710) 
 Yale University School of Medicine, Department of Cellular and Molecular Physiology, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710) 
 Departments of Biosciences and Bioengineering Rice University, Houston, USA (GRID:grid.21940.3e) (ISNI:0000 0004 1936 8278) 
 Yale University School of Medicine, Pediatric Genomics Discovery Program, Departments of Pediatrics and Genetics, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Yale University School of Medicine, Department of Cellular and Molecular Physiology, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710) 
 University of Exeter, Department of Clinical and Biomedical Sciences, Exeter, UK (GRID:grid.8391.3) (ISNI:0000 0004 1936 8024) 
Pages
6681
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2732139371
Copyright
© The Author(s) 2022. corrected publication 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.